abt-20250331
0000001800
12-31
2025
Q1
false
false
false
false
false
P12M
http://fasb.org/us-gaap/2024#LongTermDebtNoncurrent
http://fasb.org/us-gaap/2024#LongTermDebtNoncurrent
xbrli:shares
iso4217:USD
iso4217:USD
xbrli:shares
abt:segment
xbrli:pure
0000001800
2025-01-01
2025-03-31
0000001800
exch:XCHI
2025-01-01
2025-03-31
0000001800
exch:XNYS
2025-01-01
2025-03-31
0000001800
2025-03-31
0000001800
2024-01-01
2024-03-31
0000001800
2024-12-31
0000001800
us-gaap:CommonStockMember
2024-12-31
0000001800
us-gaap:CommonStockMember
2023-12-31
0000001800
us-gaap:CommonStockMember
2025-01-01
2025-03-31
0000001800
us-gaap:CommonStockMember
2024-01-01
2024-03-31
0000001800
us-gaap:CommonStockMember
2025-03-31
0000001800
us-gaap:CommonStockMember
2024-03-31
0000001800
us-gaap:TreasuryStockCommonMember
2024-12-31
0000001800
us-gaap:TreasuryStockCommonMember
2023-12-31
0000001800
us-gaap:TreasuryStockCommonMember
2025-01-01
2025-03-31
0000001800
us-gaap:TreasuryStockCommonMember
2024-01-01
2024-03-31
0000001800
us-gaap:TreasuryStockCommonMember
2025-03-31
0000001800
us-gaap:TreasuryStockCommonMember
2024-03-31
0000001800
us-gaap:RetainedEarningsMember
2024-12-31
0000001800
us-gaap:RetainedEarningsMember
2023-12-31
0000001800
us-gaap:RetainedEarningsMember
2025-01-01
2025-03-31
0000001800
us-gaap:RetainedEarningsMember
2024-01-01
2024-03-31
0000001800
us-gaap:RetainedEarningsMember
2025-03-31
0000001800
us-gaap:RetainedEarningsMember
2024-03-31
0000001800
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2024-12-31
0000001800
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2023-12-31
0000001800
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2025-01-01
2025-03-31
0000001800
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2024-01-01
2024-03-31
0000001800
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2025-03-31
0000001800
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2024-03-31
0000001800
us-gaap:NoncontrollingInterestMember
2024-12-31
0000001800
us-gaap:NoncontrollingInterestMember
2023-12-31
0000001800
us-gaap:NoncontrollingInterestMember
2025-01-01
2025-03-31
0000001800
us-gaap:NoncontrollingInterestMember
2024-01-01
2024-03-31
0000001800
us-gaap:NoncontrollingInterestMember
2025-03-31
0000001800
us-gaap:NoncontrollingInterestMember
2024-03-31
0000001800
2023-12-31
0000001800
2024-03-31
0000001800
country:US
us-gaap:OperatingSegmentsMember
abt:EstablishedPharmaceuticalProductsMember
abt:KeyEmergingMarketsMember
2025-01-01
2025-03-31
0000001800
us-gaap:NonUsMember
us-gaap:OperatingSegmentsMember
abt:EstablishedPharmaceuticalProductsMember
abt:KeyEmergingMarketsMember
2025-01-01
2025-03-31
0000001800
us-gaap:OperatingSegmentsMember
abt:EstablishedPharmaceuticalProductsMember
abt:KeyEmergingMarketsMember
2025-01-01
2025-03-31
0000001800
country:US
us-gaap:OperatingSegmentsMember
abt:EstablishedPharmaceuticalProductsMember
abt:KeyEmergingMarketsMember
2024-01-01
2024-03-31
0000001800
us-gaap:NonUsMember
us-gaap:OperatingSegmentsMember